×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
ERK2 Antikörper
MAPK1
Reaktivität: Human
Wirt: Kaninchen
Polyclonal
unconjugated
Produktnummer ABIN4904300
Produktdetails anti-ERK2 Antikörper
(ausblenden)
Target
Alle ERK2 (MAPK1) Antikörper anzeigen
ERK2 (MAPK1)
(Mitogen-Activated Protein Kinase 1 (MAPK1))
Reaktivität
Alle Reaktivitäten für ERK2 Antikörper
Human
Wirt
Alle Wirte für ERK2 Antikörper
Kaninchen
Klonalität
Alle Klonalitäten für ERK2 Antikörper
Polyklonal
Konjugat
Alle Konjugate für ERK2 Antikörper
Dieser ERK2 Antikörper ist unkonjugiert
Applikation
Bitte anfragen
Produktmerkmale
Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (MAPK1) signaling pathway can be activated in response to a diverse range of extracellular stimuli including mitogens, growth factors, and cytokines (1-3) and is an important target in the diagnosis and treatment of cancer (4). Upon stimulation, a sequential three-part protein kinase cascade is initiated, consisting of a MAP kinase kinase kinase (MAPKKK or MAP3K), a MAP kinase kinase (MAPKK or MAP2K), and a MAP kinase (MAPK). Multiple p44/42 MAP3Ks have been identified, including members of the Raf family, as well as Mos and Tpl2/Cot. MEK1 and MEK2 are the primary MAPKKs in this pathway (5,6). MEK1 and MEK2 activate p44 and p42 through phosphorylation of activation loop residues Thr202/Tyr204 and Thr185/Tyr187, respectively. Several downstream targets of p44/42 have been identified, including p90RSK (7) and the transcription factor Elk-1 (8,9). p44/42 are negatively regulated by a family of dual-specificity (Thr/Tyr) MAPK phosphatases, known as DUSPs or MKPs (10), along with MEK inhibitors such as U0126 and PD98059.
Aufreinigung
Affinity purification
Immunogen
A synthetic peptide of human MAPK1.
Isotyp
IgG
Top Product
Discover our top product MAPK1 Primärantikörper
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Applikationshinweise
WB 1:500-1:2000 , IHC 1:50-1:100
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Format
Liquid
Konzentration
1 mg/mL
Buffer
PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.4
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C.
Details zu ERK2
(ausblenden)
Target
ERK2 (MAPK1)
(Mitogen-Activated Protein Kinase 1 (MAPK1))
Andere Bezeichnung
MAPK1 (MAPK1 Produkte )
Synonyme
ERK-1 antikoerper, ERK1 antikoerper, ERT2 antikoerper, HS44KDAP antikoerper, HUMKER1A antikoerper, P44ERK1 antikoerper, P44MAPK antikoerper, PRKM3 antikoerper, p44-ERK1 antikoerper, p44-MAPK antikoerper, Erk-1 antikoerper, Erk1 antikoerper, Ert2 antikoerper, Esrk1 antikoerper, Mnk1 antikoerper, Mtap2k antikoerper, Prkm3 antikoerper, p44 antikoerper, p44erk1 antikoerper, p44mapk antikoerper, ERK antikoerper, ERK2 antikoerper, ERT1 antikoerper, MAPK2 antikoerper, P42MAPK antikoerper, PRKM1 antikoerper, PRKM2 antikoerper, p38 antikoerper, p40 antikoerper, p41 antikoerper, p41mapk antikoerper, 9030612K14Rik antikoerper, AA407128 antikoerper, AU018647 antikoerper, C78273 antikoerper, Erk2 antikoerper, Prkm1 antikoerper, p42mapk antikoerper, zERK2 antikoerper, MAPK1 antikoerper, Xp42 antikoerper, erk antikoerper, erk2 antikoerper, ert1 antikoerper, mapk antikoerper, mapk1b antikoerper, mapk2 antikoerper, mpk1 antikoerper, prkm1 antikoerper, prkm2 antikoerper, mapk1 antikoerper, mapk1a antikoerper, xp42 antikoerper, ATMPK1 antikoerper, F14N23.9 antikoerper, F14N23_9 antikoerper, MITOGEN-ACTIVATED PROTEIN KINASE antikoerper, mitogen-activated protein kinase 1 antikoerper, MNK1 antikoerper, ATMPK2 antikoerper, MITOGEN-ACTIVATED PROTEIN KINASE HOMOLOG 2 antikoerper, T30E16.13 antikoerper, T30E16_13 antikoerper, mitogen-activated protein kinase homolog 2 antikoerper, mitogen-activated protein kinase 3 antikoerper, mitogen-activated protein kinase 1 antikoerper, mitogen activated protein kinase 1 antikoerper, mitogen-activated protein kinase 1 L homeolog antikoerper, mitogen-activated protein kinase 1 S homeolog antikoerper, mitogen activated protein kinase 3 antikoerper, mitogen-activated protein kinase homolog 2 antikoerper, MAPK3 antikoerper, Mapk3 antikoerper, MAPK1 antikoerper, Mapk1 antikoerper, mapk1 antikoerper, mapk1.L antikoerper, mapk1.S antikoerper, PfMAP1 antikoerper, MPK1 antikoerper, PVX_084965 antikoerper, LOC9328617 antikoerper, Tsp_01601 antikoerper, MPK2 antikoerper
Gen-ID
5594
UniProt
P28482
Pathways
MAPK Signalweg , RTK Signalweg , Apoptose , Interferon-gamma Pathway , Fc-epsilon Rezeptor Signalübertragung , Response to Growth Hormone Stimulus , Activation of Innate immune Response , Cellular Response to Molecule of Bacterial Origin , Hepatitis C , Protein targeting to Nucleus , Toll-Like Receptors Cascades , Monocarboxylic Acid Catabolic Process , Autophagie , G-protein mediated Events , Signaling Events mediated by VEGFR1 and VEGFR2 , Signaling of Hepatocyte Growth Factor Receptor , VEGFR1 Specific Signals , BCR Signaling , S100 Proteine
Zuletzt angesehen
(ausblenden)